SUCAMPO PHARMACEUTICALS INC. Up to $20,000,000 Shares of Class A Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • December 21st, 2012 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Sucampo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
